Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FWB: L0MA) (“Nextleaf”, “OILS” or the “Company”), a government-regulated cannabis oil manufacturer that owns one of the largest portfolios of cannabis oil for US patents Cannabinoid Extraction and Distillation, today announced the launch of the Prohibition-era CBD 100 Distilled Oil and CBD 200 Distilled Oil under the company’s Glacial Gold ™ brand.
Glacial Gold ™ Distilled CBD 200 Oil is a first in the Canadian adult and medical market, with the highest amount of CBD in a single unit (5700 mg), the highest CBD potency available in an ingestible oil format (200 mg) mg / g =.). 20%) and the best dollar value per milligram for CBD in both the legal and illegal markets in Canada.
Glacial Gold Distilled CBD 100 Oil & Distilled CBD 200 Oil
To view an improved version of this graphic, please visit:
The company’s multi-patented winterization and filtration technology is the secret behind the production of high-purity CBD distillate that is free from waxes, sugars and other undesirable compounds.
A recent research report from CBC Marketplace showed that the unregulated market for CBD is full of misleading claims and contaminants that are harmful to consumers and would not meet the standards of the regulated market.
“We are proud to be the first to introduce a highly potent CBD product in Canada. By leveraging Nextleaf’s competitive advantage to produce high-purity distillate on a large scale, we can offer the range of Glacial Gold CBD products at breakthrough prices, ”said Paul Pedersen, CEO and Co-Founder of Nextleaf. “When consumers buy Glacial Gold products, they trust that every milliliter is standardized for a predictable, safe, and repeatable result that can be achieved with products obtained from illicit sources, including unregulated CBD products used in the USA made, simply cannot be guaranteed. ”
Based on the early success of Glacial Gold ™ Distilled CBD 50 Oil by retailers in British Columbia, Nextleaf is launching its new Glacial Gold ™ Distilled CBD 100 & Distilled CBD 200 Oils. This adds a range of potencies for low, medium and high dose CBD consumers to Glacial Gold’s Distilled CBD Oil product range. All Glacial Gold CBD oil products are made from sun-grown hemp by Nextleaf.
Glacial Gold ™ CBD and THC products are currently being sold across British Columbia with plans to expand nationwide next year.
Glacial Gold ™ products are made available to medical cannabis patients across Canada through mendocannabis.ca.
Glacial Gold ™ 60 Day Review
Nextleaf launched its Prohibition-era Glacial Gold ™ brand in British Columbia, the company’s home province, in early September. After two months of sales, the brand continues to attract national attention for its quality distillate and accessible prices from consumers, patients and retailers alike. Nextleaf continues to see increasing demand in the province of British Columbia, including larger orders. Some important milestones and key figures in September and October:
- Launch of 7 SKUs of Glacial Gold ™ THC and CBD products in BC, consisting of four 1 gram vape SKUs and three distilled oil SKUs
- The addition of distilled CBD 100 & CBD 200 oils amounts to 9 Glacial Gold ™ SKUs listed in BC within the first 60 days of initial launch
- 60% + retail penetration rate with Glacial Gold ™ in BC
- Best-priced 1g vape cart in Canada (1: 1 vape anytime)
- High Quality CBD Oil Made In Canada (Distilled CBD 50 Oil)
- Signed an agreement with Quebec-based medical cannabis platform Mendocannabis.ca to distribute Glacial Gold ™ to medical cannabis patients across Canada
- Signed an agreement with National Cannabis Distribution Inc., a wholly owned subsidiary of Kiaro Holdings Corp., to distribute Glacial Gold ™ in Saskatchewan
Nextleaf is a government-regulated cannabis oil manufacturer with one of the largest portfolios of US patents for the extraction and distillation of cannabinoids. Nextleaf sells cannabis vapes and distilled oils under its award-winning Glacial Gold ™ brand from the Prohibition era and supplies its wholesale customers with cannabis distillate. Nextleaf’s proprietary closed-loop, automated extraction facility in Metro Vancouver efficiently converts cannabis and hemp grown in British Columbia and across Canada to high-purity cannabis distillate on an industrial scale. As part of its Health Canada Research License, Nextleaf is developing a delivery technology and differentiated cannabinoid-based formulations with sensory evaluation of cannabis through tests on humans. The company owns 17 US patents and has received 90 patents worldwide.
Nextleaf Solutions is traded as OILS on the Canadian Stock Exchange, as OILFF on the OTCQB market in the United States, and as L0MA on the Frankfurt Stock Exchange.
Follow the company on social platforms: Twitter, LinkedIn, Facebook and Instagram.
Follow Glacial Gold ™ on social platforms: Instagram, Twitter and Facebook. www.Glacial.Gold
For more information, please contact:
Jason McBride, business development
604-283-2301 (ext. 219)
On behalf of the Board of Directors of the Company,
Paul Pedersen, CEO
Certain statements in this press release are “forward-looking statements”. All statements that are not historical facts contained in this news release including, but not limited to, the company’s ability to capitalize on its IP portfolio, the company’s strategy, plans, goals, objectives and objectives, and all of them Statements preceded and followed by the words “believe”, “expect”, “aim”, “intend”, “plan”, “continue”, “will”, “may”, “would”, “anticipate” “,“ Estimate ”,“ forecast ”,“ forecast ”,“ project ”,“ search ”,“ should ”or similar expressions or the negative thereof are forward-looking statements. These statements are not historical facts, but merely represent the company’s expectations, estimates and projections of future events. These statements are not guarantees of future performance and involve assumptions, risks, and uncertainties that are difficult to predict. As a result, actual results could differ materially from what is expressed, implied or projected in such forward-looking statements. Other factors that could cause actual results, performance, or achievements to differ materially include the risk factors discussed in the company’s MD&A for the most recent fiscal year. Management makes forward-looking statements in the belief that they will provide investors with useful information based on their investment objectives and cautions investors not to place undue reliance on forward-looking information. Consequently, all forward-looking statements in this press release are limited by these cautionary statements and other warnings or factors contained herein, and no assurance can be given that actual results or developments will be realized or, even if they will materialize, those anticipated Will have consequences for the company. These forward-looking statements speak as of the date of this press release and the company undertakes no obligation to update or revise them to reflect future information, events or circumstances or otherwise, except as required by law. The CSE has not reviewed or approved the contents of this press release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/101830